Internal Medicine Department
Hematology Division

Donghoon Yoon, PhD

Email:   dong.yoon@hsc.utah.edu

Education:

1998 – 2004    Ph.D. in Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas

1994 – 1997    M.A. in Animal and Dairy Sciences, Auburn University, Auburn, Alabama

1986 – 1990    B.S. in Genetic Engineering, Sung Kyun Kwan University, Seoul, Korea

Training:

2006 – 2007    Postdoctorate Associate in Hematology, University of Utah Health Sciences Center, Salt Lake City, UT

2004 – 2006    Postdoctorate Associate in Hematology/Oncology, Baylor University, Houston, TX

Research Interests:    

Erythropoietin signaling pathway
Hypoxia responses

Bibliography

  1. Yoon D, Kim BJ, Prchal JT. (Submitted). Hematopoietic specific GATA-1-improved Cre mouse for erythroid-specific gene modification. Br J Hematol.
  2. Domenico ID, Vaughn MB, Yoon D, Kushner JP, Ward DM,Kaplan J. (In Press). Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations. Blood.
  3. Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT. (In Press). The regulated expression of miRNAs in normal and polycythemia vera erythropoiesis. J Exp Hematol.
  4. Gaikwad A, Verstovsek S, Yoon D, Chang KT, Manshouri T, Nussenzveig R, Cortes J, Vainchenker W, Prchal JT. (2007). Imatinib effect on growth and signal transduction in polycythemia vera. J Exp Hematol, 35(6):931-8.
  5. Yoon D, Pastore YD, Divoky V, Liu E, Mlodnicka AE, Rainey K, Ponka P, Semenza GL, Schumacher A, Prchal JT. (2006). Hypoxia–inducible factor–1 deficiency results in dysregulated erythropoietin signaling and iron homeostasis in mouse development. J Biol Chem, 281(35):25703-25711.
  6. Mnjoyan Z, Yoon D, Li J, Delhommeau F, and Afshar-Kharghan V. (2006). JAK2 Mutation Increases PRV-1 Expression. Haematologica, 91:411-412.
  7. Yoon D, and Watowich SS. (2003). Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway. Exp Hematol, 31:1310-1316.